/  News Items

News Items

Press Release - House Passes REINS Act to Limit Excessive Federal Regulations; Bill Included Sessions Amendment to Analyze Impact of Regulations on Jobs

Jul 28, 2015

Washington, D.C. – U.S. Congressman Pete Sessions (R-TX), chairman of the House Rules Committee, today issued the following joint statement after the House’s passage of a bill requiring a joint resolution of approval by the Congress and the president’s signature before any new executive action takes effect. The bill included an amendment authored by Chairman Sessions and Congressmen Andy Barr (R-KY), Rodney Davis (R-IL) and Brad Wenstrup (R-OH) that would require analysis on the impact of federal regulations on jobs.

Press Release - Sessions Applauds Passage of Enforce the Law for Sanctuary Cities Act

Jul 23, 2015

WASHINGTON, D.C. – U.S. Congressman Pete Sessions (R-TX), chairman of the House Rules Committee, today issued the following statement on the House’s passage of legislation which prohibits federal grants to be given to local governments unwilling to assist the federal government in enforcing measures that distinguish between residents with legal immigration status and those who lack authorization under federal law to be present in the United States:

Press Release - Sessions Applauds Passage of Highway Funding Act

Jul 15, 2015

WASHINGTON, D.C. – U.S. Congressman Pete Sessions (R-TX), chairman of the House Rules Committee, today issued the following statement following the House’s passage of a spending measure to fund federal surface and hazardous materials transportation programs through December 18, 2015:

Press Release - Sessions Calls Passage of 21st Century Cures Act a “Historic Opportunity” to Modernize Health Care Infrastructure

Jul 10, 2015

WASHINGTON, D.C. – U.S. Congressman Pete Sessions (R-TX), chairman of the House Rules Committee, today issued the following statement after voting in support of the 21st Century Cures Act, an effort led by House Republicans to modernize and personalize health care, encourage innovation, support research and streamline drug and device approval, which passed the House:

Pages